RAC1 and hepatocellular carcinoma: The down-regulation of RAC1 by MG53 in HCC cells was effectively abrogated after the treatment with the proteasome inhibitor MG132, which indicated that MG53 negatively regulated RAC1 by proteasome-mediated degradation (Fig. 3B).